# Long-term Study Of Ropinirole In Restless Legs Syndrome

> **NCT00329602** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 404 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DRUG:** Placebo
- **DRUG:** Ropinirole

## Key facts

- **NCT ID:** NCT00329602
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 404 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329602, "Long-term Study Of Ropinirole In Restless Legs Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00329602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*